Study about clinical characteristics and molecular markers of carcinosarcoma of the uterus

Recruiting

• Conditions: cancer of the uterus; carcinosarcoma of the uterus; 10038594; 10013364

• Registration Number: NL-OMON51322
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

Female patients older than 18 year who are diagnosed with a histologically
confirmed CSU. Patients will be asked to sign informed consent.
Patients are also able to choose if they want to participate in a part of the
study (molecular analysis, registration of clinical outcomes and/or
participation in quality of life questionnaires). Patients who are already
included for the CUS-study can for additionally join the CUS II study for the
molecular analysis.

Exclusion Criteria

Patients who are not able to fill in the questionnaires due to language (Dutch)
or who are not mentally competent are excluded for the part of quality of life.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>molecular characterization of the obtained tumor tissue, liquid biopsies and<br /><br>papsmear.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Quality of life-questionnaires and registration of clinical outcomes of<br /><br>included subjects.</p><br>